Change Agents Corporation

Change Agents Corporation

CHGA · NASDAQ · Real Estate / Real Estate Services

1.06USD+0.12 (+12.87%)

Price History

Full chart

Market Stats

Previous Close0.9391
Open0.95
Day Range0.935 – 1.13
52-Week Range1.80 – 49.88
Volume137.49K
Market Cap2.31M
P/E (TTM)0.05
Forward P/E0.00
EPS40.65
Dividend Yield0.00%
Beta-0.06
50-Day Avg3.51
200-Day Avg10.76

About

Change Agents Corporation, together with its subsidiaries, develops innovative artificial intelligence platforms in the United States and China. It operates through Consumer Health Technology and Artificial Intelligence Content Technology Segment. The company offers automated video generation, enterprise documentation, and workflow automation solutions, as well as cellular therapy and generative AI publishing and software. It also distributes the KetoAir device, which is a breathalyzer system that detects acetone levels in exhaled breath; and the AI Nutritionist software program that helps users monitor and manage ketogenic diet and related programs. The company was formerly known as Avalon GloboCare Corp. and changed its name to Change Agents Corporation in July 2026. Change Agents Corporation was founded in 2015 and is headquartered in Freehold, New Jersey.

Company Details

  • SectorReal Estate
  • IndustryReal Estate Services
  • CEOMs. Meng Li
  • Employees2
  • Headquarters4400 Route 9 South, Freehold, NJ, United States, 07728, USA
  • Websitehttps://ir.changeagentscorp.com

Leadership

  • Ms. Meng LiInterim CEO, COO & Secretary · b. 1978
  • Ms. Luisa IngargiolaChief Strategy Officer · b. 1967
  • Mr. Samuel J. KnipperChief Financial Officer · b. 1995

Financials

Income Statement

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.33M1.20M1.26M-846.59K0
Growth (%)--9.65%+4.45%-167.42%+100.00%
Cost of Revenue-929.44K1.02M123.16K-
Gross Profit1.33M272.73K238.19K-846.59K-
Gross Margin100.00%22.69%18.97%100.00%-
Operating Expense10.16M7.72M7.42M3.99M-
Operating Income-8.83M-7.44M-7.18M-4.84M-7.59M
Operating Margin-663.94%-619.12%-571.96%571.85%-
EBITDA--7.89M-15.03M-3.87M-15.90M
EBITDA Margin--656.17%-1196.61%457.31%-
Net Income-9.09M-11.93M-16.71M-7.90M-18.26M
Net Income Margin-683.23%-992.44%-1330.51%933.56%-
R&D1.03M731.33K109.62K--
R&D as % of Total Revenue77.04%60.83%8.73%--
Interest Expense200.48K3.58M1.35M1.66M1.46M
Interest Expense % of Total Revenue15.07%297.49%107.63%-196.05%-

Balance Sheet

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-19.75M20.58M20.99M23.40M
Total Liabilities-8.59M13.21M13.88M14.17M
Total Equity-11.16M7.37M7.10M9.23M
Cash-1.99M285.40K2.66M109.09K
Total Debt----940.36K
Net Debt-2.57M8.09M4.97M831.27K

Cash Flow

Currency: USD2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-5.02M-7.04M-6.50M-4.96M-4.99M
Investing Cash Flow-68.14K-9.05M-22.16K-100.00K1.05M
Financing Cash Flow5.17M17.26M4.83M7.64M1.40M
Capital Expenditure09.00M22.16K00
Free Cash Flow-5.02M-16.04M-6.53M-4.96M-4.99M
FCF to OCF100.00%227.91%100.34%100.00%100.00%

Earnings

Report DateDec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Aug 14, 2026Nov 13, 2026
EPS Estimate----------------------------------------
EPS Actual4.00-26.33-19.98-32.99-75.72-63.69-53.95-96.92-108.58-179.36-173.86-152.97-214.49-127.91-116.23-121.01-113.49-85.13-83.84-71.14-81.24-70.19-68.43-167.39-72.81-83.39-74.45-41.27-269.18-37.20-57.01-544.94-39.78-30.56-124.48-1.25-0.43-9.99-0.14-
Surprise----------------------------------------
Timing----------------------------------------

Key Statistics & Ratios

Market Cap2.31M
Enterprise Value21.14M
Trailing P/E0.05
Forward P/E0.00
Price / Sales0.00
Price / Book7.51
EPS40.65
Book Value-10.65
Revenue (TTM)0
Gross Profit (TTM)0
EBITDA-5.45M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity-576.07%
Return on Assets-36.72%
Shares Outstanding1.12M
Shares Float989.55K
Beta-0.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
2.06%
Insiders
31.33%
Retail / Other
66.61%

Top Institutional Holders

  • Citadel Advisors Llc
    86.80K0.44%
  • Geode Capital Management, LLC
    61.95K0.31%
  • Equitable Holdings Inc
    60.00K0.30%
  • Vanguard Capital Management, LLC
    57.33K0.29%
  • HRT FINANCIAL LLC
    40.41K0.20%
  • Scientech Research LLC
    40.37K0.20%
  • Morgan Stanley - Brokerage Accounts
    27.60K0.14%
  • Procyon Private Wealth Partners, LLC
    21.52K0.11%
  • StoneX Group Inc
    20.00K0.10%
  • Vanguard Fiduciary Trust Co
    18.39K0.09%
  • XTX Topco Ltd
    17.32K0.09%
  • TWO SIGMA SECURITIES, LLC
    15.34K0.08%
  • JONES FINANCIAL COMPANIES LLLP
    10.00K0.05%
  • UBS Group AG
    5.54K0.03%
  • Tower Research Capital LLC
    4.29K0.02%
  • Advisor Group Holdings, Inc.
    1.00K0.01%
  • SBI Securities Co Ltd
    70.00%
  • Smallwood Wealth Investment Management, LLC
    50.00%

Top Fund Holders

  • Fidelity Extended Market Index
    69.66K1.44%
  • Fidelity Series Total Market Index
    2.64K0.05%

Stock Splits

  • Aug 31, 20261:20
  • Oct 28, 20241:15
  • Jan 5, 20231:10